Geron laying off 43 more, ending brain cancer drug program

Geron Corp. will shed 43 jobs, kill its brain cancer drug program and focus development on another cancer drug, called imetelstat, the company said Monday.

http://www.bizjournals.com/sanfrancisco/blog/biotech/2012/12/geron-gern-brain-cancer-stem-cells.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_38+%28Health+Care+Regulation+Industry+News%29